CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse(R) On-Body Delivery System (OBDS), announced today that Sanofi is making a $30 million investment to accelerate Enable's manufacturing build-out, strengthen its supply chain capabilities, and drive commercial growth. “This investment from one of our key […]

(TSX-V:RYO),(OTC US:RYOOF),(Other OTC:RYOOF), VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) — Rio Silver Inc. (TSX-V: RYO | OTC: RYOOF) (“Rio Silver” or the “Company”) is pleased to provide an update on its Maria Norte gold-silver-lead-zinc Project in central Peru, following the completion of recent technical work and site activities conducted in accordance with National

(NASDAQ:CGTX), PURCHASE, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX), today announced that a manuscript entitled, “Phase 2 Study of Zervimesine (CT1812) in Participants with Mild-to-Moderate Dementia with Lewy Bodies (DLB)” (doi: 10.1002/alz.71004) has been published in the journal, Alzheimer's & Dementia, the journal of the Alzheimer's Association. Results from this

(NASDAQ:AVXL), NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that the U.S. Food

(NASDAQ:RGEN), WALTHAM, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Board has elected Dr. Martin D. Madaus as Chair of the Board, effective March 13, 2026. As previously communicated1, Tony Hunt is retiring from his role as Executive Chair and

(NASDAQ:BVS), DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 9:45 a.m. PT (12:45 p.m. ET). The live webcast of

Seasoned biotech executive brings over 25 years of leadership experience across financial strategy and operations, investor relations and business development DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced the appointment of McDavid

(NASDAQ:EDBL),(NASDAQ:EDBLW), BELVIDERE, NJ, Jan. 06, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce and products, today announced a 26.4% year-over-year increase in preliminary sales during the Company's key holiday selling period1 in

(NASDAQ:BFRG),(NASDAQ:BFRGW), GAITHERSBURG, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, highlights the presentation of data derived from the use of the Company's proprietary platform bfLEAP(R) with

(NYSE:SLG), NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, and Rockpoint, a Boston-based real estate private equity firm, today announced a joint venture for the ownership of 100 Park Avenue through SL Green's sale of a 49% interest to Rockpoint at a gross asset valuation of